Locations:

Tag: yogen saunthararajah

January 10, 2019/Cancer/Research

Efficacy of a First-in-Class SMARCA5/CHD4 Inhibitor in Cell-Based Assays of Acute Myeloid Leukemia

First agent in a new class of noncytotoxic cancer drugs

November 14, 2018/Cancer/Research

How Nucleophosmin Mutation Causes Acute Myeloid Leukemia

Groundbreaking study paves way for targeted therapy

November 20, 2017/Cancer/Research

New Sickle Cell Disease Treatment Shows Positive Results in Phase 1 Clinical Trial

Novel drug could greatly improve patient outcomes

June 29, 2017/Cancer/Research

Non-Cytotoxic Epigenetic Therapy for p53-Mutant/p16-Deleted Solid and Liquid Cancers

Three clinical trials underway

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next